Merit Medical Systems Q2 2024 Adj EPS $0.92 Beats $0.87 Estimate, Sales $338.00M Beat $334.55M Estimate
Merit Medical Systems Q2 2024 Adj EPS $0.92 Beats $0.87 Estimate, Sales $338.00M Beat $334.55M Estimate
Merit Medical Systems 2024年第二季度每股收益$0.92，超出预期的$0.87，销售额为$33800万，超出预期的$33455万。
Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.87 by 5.75 percent. The company reported quarterly sales of $338.00 million which beat the analyst consensus estimate of $334.55 million by 1.03 percent. This is a 5.61 percent increase over sales of $320.06 million the same period last year.
Merit Medical Systems (纳斯达克:MMSI)报告每股盈利为$0.92，超出分析师共识预估($0.87)5.75%。公司报告季度销售额为$3,3800万，超出分析师共识预估($3,3455万)1.03%。这是相对于去年同期销售额$3,2006万的增长5.61%。